Home » CSMG TECHNOLOGIES RECEIVES ADDITIONAL U.S. PATENT FOR TISSUE WELDING/BONDING TECHNOLOGY

CSMG TECHNOLOGIES RECEIVES ADDITIONAL U.S. PATENT FOR TISSUE WELDING/BONDING TECHNOLOGY

May 10, 2006

CSMG Technologies, Inc., announced today announced today that it has received an additional U.S. patent for its platform tissue welding/bonding technology.
CSMG

KEYWORDS FDAnews Device Daily Bulletin

10Mar
FDA Drug GMP Facility Inspections During the Pandemic
16Mar
Pharmaceutical Naming Regulation: Understanding the Latest Developments
18Mar
Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19
23Mar
Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges
30Mar
Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges
06Apr
Medical Device Cybersecurity: Understand the Latest Developments

CSMG TECHNOLOGIES RECEIVES ADDITIONAL U.S. PATENT FOR TISSUE WELDING/BONDING TECHNOLOGY

Upcoming Events

FDA Drug GMP Facility Inspections During the Pandemic

Pharmaceutical Naming Regulation: Understanding the Latest Developments

Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

President Biden Issues Executive Order on U.S. Supply Chain

Priority Healthcare Settles Diabetes Test Lawsuit with Roche for $43 Million

Pfizer/BioNTech Vaccine Equally Effective for All Age Groups, Israeli Study Says

Siemens Healthineers’ COVID-19 Antigen Lab Test Receives CE Mark

The Revised ICH E8: A Guide to New Clinical Trial Requirements